NeuroTech.com
Mind · Machine · Consciousness

The age of the
mind-machine
is here.

The future of consciousness, tracked daily.

Neurotechnology is rewriting what it means to be human — and what it means to be intelligent. We track the companies, breakthroughs, and ideas at this frontier, so you don't miss a moment of the most important shift in the history of mind.

"The question is no longer whether machines can think —but whether they can learn to love."

New

Shop neurotech products

EEG headsets, sleep wearables and brain stimulation devices you can buy today.

Browse products →

Browse by category

View all 790 companies →

Featured companies

View all →
K

Kernel

Research Tools

Featured

Kernel builds non-invasive neuroimaging helmets — the Flow (TD-fNIRS) and Flux (MEG) systems — designed to make high-resolution brain scanning accessible outside of hospital settings. Founded by Bryan Johnson, the company aims to democratize neuroscience research and brain measurement at scale.

Private · $53M+Visit →
M

MindMed

Psychedelics

Featured

MindMed is a clinical-stage psychedelic medicine company developing novel therapeutics derived from LSD, MDMA, and ibogaine analogs for neurological and psychiatric disorders. Their lead asset MM120 (LSD tartrate) has shown promising Phase 2b results for generalized anxiety disorder.

NASDAQ: MNMDVisit →

Recently added

Full directory →
MT

Myelin Therapeutics

Neuropharmaceuticals · Cambridge, MA

↗
NL

Neural Leap

Cognitive Health · Toronto, Ontario, Canada

↗
PN

Paradox Neurotechnologies

Neuromodulation · Minneapolis, MN

↗
CN

CortiSync Neuro

Brain-Computer Interfaces · Pittsburgh, PA

↗
MD

MindWave Diagnostics

Neurodiagnostics · Toronto, Ontario, Canada

↗
NB

Neurexo Biosciences

Neuropharmaceuticals · San Diego, CA

↗
NM

Nalu Medical

Neuromodulation · Carlsbad, California, USA

↗
N

Neurolutions

Brain-Computer Interfaces · St. Louis, Missouri, USA

↗
💰

Funding spotlight

🏢

Myelin Therapeutics

Series A — $28M

🏢

Neural Leap

Seed — $3.5M

🏢

Paradox Neurotechnologies

Series B — $42M

🏢

CortiSync Neuro

Seed — $8M

🏢

MindWave Diagnostics

Series B — $61M

🏢

Neurexo Biosciences

Series A — $42M

Latest news

All →
💰Funding2026-10-28
NeuroXess Raises 700 Million Yuan in Series B to Push 'Three-Comprehensive' BCI Into Clinical Trials

Chinese BCI company NeuroXess has closed a 700 million yuan Series B round as its implantable brain-computer interface enters registration clinical trials.

🔬Research2026-10-27
BCI Stimulation Shows Stronger Recovery Signal After Stroke, Landmark Review Finds

A new review finds brain-computer interface stimulation produces clearer neurological recovery signals in stroke patients than previously understood.

💰Funding2026-10-26
Flourish Emerges From Stealth With Bezos and Google Ventures Backing to Tackle Neuroscience

Catalio-backed neuroscience startup Flourish has launched with investment from Bezos Expeditions and Google Ventures.

🚀Product2026-10-25
FDA Grants De Novo Approval to Modius Spero Neuromodulation Device for PTSD

The FDA has granted De Novo approval to Modius Spero, marking a significant regulatory milestone for wearable neuromodulation in PTSD treatment.

💰Funding2026-10-24
Wearable Neurofeedback Startup BRYM Secures €650K to Build Next-Generation Brain Training Platform

BRYM has raised €650K to develop a wearable neurofeedback platform, signaling continued investor appetite for consumer-grade brain training tech.

🔬Research2026-10-23
Brain-Computer Interface Gives Unresponsive ICU Patients Auditory Control for the First Time

A new BCI allows unresponsive ICU patients to control sounds, marking a significant step toward communication for the most critically ill.

📋Policy2026-10-22
China Moves to Standardise Brain-Computer Interface Technology, Reshaping Global Neurotech Governance

China takes a formal step toward standardising BCI technology, signaling a major shift in how nations govern mind-machine interfaces.

🧠Industry2026-10-21
BCI Market Projected to Sustain 17.9% CAGR Through 2033 as Investment and Clinical Activity Accelerate

A new market forecast projects the BCI sector will grow at 17.9% CAGR from 2024 to 2033, reflecting surging clinical and commercial momentum.

Every Sunday

The NeuroTech Digest

Funding rounds, breakthroughs, and top jobs — curated weekly for industry professionals.

Subscribe free →

For companies

Reach neurotech decision-makers

Premium listings, newsletter sponsorships, and featured placements.

View packages →

News & insights

All articles →

The field, by the numbers

790+

Companies mapped

across 9 sectors

$18B+

VC invested

in the field globally

3×/week

News published

Mon · Wed · Fri

109+

Articles

research & industry

Companies by sector

🧠

28

Brain-Computer

💭

16

Cognitive

💙

29

Mental

⚡

44

Neuromodulation

💊

39

Neuropharmaceuticals

🔬

27

Neurodiagnostics

🔭

11

Research

📊

13

Neurofeedback

🍄

39

Psychedelics

Every Sunday

The NeuroTech Digest

The signal through the noise — breakthroughs, funding, and ideas at the edge of mind and machine. Curated weekly.

No spam. Unsubscribe anytime.